Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease

Arash Rashidi, Pranav S. Garimella, Abdullah Al-Asaad, Talar Kharadjian, Mariela Navarro Torres, Jyotsana Thakkar

Research output: Contribution to journalReview articlepeer-review

Abstract

Anemia is a common medical problem among patients with cancer and chronic kidney disease (CKD). Although anemia in patients with CKD is often treated with iron and erythropoietin-stimulating agents, there are controversies with regard to the use of erythropoietin-stimulating agents in cancer patients. In this article, we review the treatment of anemia in patients with cancer and CKD, in addition to summarizing the current guidelines in treatment of anemia in these patients.

Original languageEnglish (US)
Pages (from-to)180-187.e1
JournalAdvances in Chronic Kidney Disease
Volume29
Issue number2
DOIs
StatePublished - Mar 2022

Keywords

  • Anemia
  • CKD
  • Cancer
  • Dialysis
  • ESA
  • Iron

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease'. Together they form a unique fingerprint.

Cite this